Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00024518 · ClinicalTrials.gov registry record · Phase 2
Interferon-Alpha for Diabetes Mellitus Type 1
A Phase 2 study of Insulin-dependent Diabetes Mellitus, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 2
- Development phase
- 57
- Enrollment target
- 5
- Study locations
NCT00024518 is a Phase 2 study of Insulin-dependent Diabetes Mellitus that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 57 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT00024518, a Phase 2 study of Insulin-dependent Diabetes Mellitus, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 57 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study will see if interferon-alpha given early in the disease can stop or slow the immune attack on insulin-producing cells. In addition, the study will examine the safety and efficacy of interferon-alpha (given by mouth) to protect beta cell function. Patients between 3 and 25 years of age with Type 1 Diabetes Mellitus less then six weeks may be eligible for this study. All study-related tests and medications at the NIH Clinical Center are provided at no cost.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG 30,000 units hrINF-alpha
- DRUG 5,000 hrINF-alpha
Study Locations (5)
Texas
- University of Texas, Dallas - Dallas
- University of Texas, Houston - Houston
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Minnesota
- Children's Hospital - St. Paul - Saint Paul
Missouri
- Children's Hospital - Kansas City - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2001-09 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00024518
The ClinicalTrials.gov registry entry for NCT00024518 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Insulin-dependent Diabetes Mellitus appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00024518 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Texas, Maryland, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00024518 about?
NCT00024518 is a clinical study titled "Interferon-Alpha for Diabetes Mellitus Type 1". This study will see if interferon-alpha given early in the disease can stop or slow the immune attack on insulin-producing cells. In addition, the study will examine the safety and efficacy of interferon-alpha (given by mouth) to protect beta cell function. Patients between 3 and 25 years of age wit...
What is the current status of trial NCT00024518?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 57 participants. The study started on 2001-09. Estimated completion is 2008-09.
What conditions does trial NCT00024518 study?
This clinical trial studies the following conditions: Insulin-dependent Diabetes Mellitus.
What interventions are being tested in trial NCT00024518?
The interventions under investigation include: Placebo (OTHER), 30,000 units hrINF-alpha (DRUG), 5,000 hrINF-alpha (DRUG).
Who is sponsoring clinical trial NCT00024518?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00024518 being conducted?
This trial has 5 study locations across Maryland, Minnesota, Missouri, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin-dependent Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.